m+Medelevator.RU
← Поиск публикаций
Journal of the Egyptian National Cancer Institute · 2026

Uterine transposition for fertility preservation prior to pelvic irradiation: an initial Egyptian case series.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Refky Basel, Abdelkhalek Mohamed, Hamdy Mohamed, Atallah Khalid, Abuzenah Amr, Zaidan Amira, Elhawari Sahar, Gadelhak Basma, Ismail Alaa, Ahmed Abou-Taleb Hisham, Gaballa Khaled

Аннотация

BACKGROUND: Recently, uterine transposition has been proposed as a novel technique for fertility preservation in young females undergoing radiation therapy for pelvic malignancies.

PATIENTS AND METHODS: This is an interventional pilot study including six female patients with pelvic malignancies planned to receive pelvic radiation aiming at preserving their fertility after a multidisciplinary team decision to have uterine transposition. Our study aims to assess the feasibility of this novel technique.

RESULTS: Six patients underwent uterine transposition. Three of them were done through open technique, with successful repositioning. The other three patients underwent laparoscopic uterine transposition, one of them underwent repositioning and still receiving chemotherapy for Ewing's sarcoma, the other two patients are still receiving radiation therapy after transposition. Unfortunately, one of them died of disease and adjuvant therapy complications four months after laparoscopic uterine transposition.

CONCLUSION: Uterine transposition is a feasible procedure with safe outcomes. The preliminary results carry a promising hope for better fertility preservation in young patients undergoing radiation for pelvic malignancies.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты